Background: Multimorbidity (the co-occurrence of two or more chronic diseases) can be seen as a prototypical situation in which psychosocial adjustment is required. Even though most patients adapt successfully, a significant number of individuals show adaptation problems and develop additional mental health problems. Objective: For this reason, this article focuses on the importance of psychosocial adaptation as a core process in the context of quality of life. Results: Important findings pointing at the association between multimorbidity and mental health are summarized, and the stress-response perspective on psychosocial adjustment is introduced. Furthermore, cognitive-affective processing of the disease (in the context of illness perceptions) and interpersonal emotion regulation are presented as relevant examples for processes involved in psychological adaptation to multimorbidity. As an intervention possibility, expressive writing is given as a feasible example. Conclusion: Viewing adjustment problems to multimorbidity from a stress-response perspective offers a framework for a deeper understanding of core processes regarding multimorbidity and quality of life that is not only important for research but also for clinical practice. This article ends with a general summary and an outlook on clinical implications of the introduced stress-response concept of adjustment to multimorbidity.

Keywords:
Multimorbidity, Mental health, Chronic illness, Psychosocial adjustment, Stress-response syndrome, Quality of life
1.
Boyd CM, Fortin M: Future of multimorbidity research: how should understanding of multimorbidity inform health system design? Public Health Rev 2010;32:451-474.
2.
Bengel J, Hubert S: Anpassungsstörung und akute Belastungsreaktion. Fortschritte der Psychotherapie. Göttingen, Hogrefe, 2010, pp 3-17.
3.
Maercker A, Einsle F, Köllner V: Adjustment disorders as stress response syndromes: a new diagnostic concept and its exploration in a medical sample. Psychopathology 2007;40:135-146.
4.
World Health Organization: The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria Research. Geneva, WHO, 1993.
5.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (DSM-5), ed 5. Washington, American Psychiatric Press, 2013.
6.
Razavi D, Stiefel F: Common psychiatric disorders in cancer patients. 1. Adjustment disorders and depressive disorders. Support Care Cancer 1994;2:223-232.
7.
American Psychiatric Association: Adjustment disorders; in Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. Washington, American Psychiatric Association 1994, pp. 623-626.
8.
Simmen-Janevska K, Maercker A: Anpassungsstörungen: Konzept, Diagnostik und Interventionsansätze. Psychother Psych Med 2011;61:183-192.
9.
Paykel ES, Brigja T, Fryers T: Size and burden of depressive disorders in Europe. Eur Neuropsychopharmacol 2005;15:411-423.
10.
Wittchen HU, Hoyer J: Klinische Psychologie und Psychotherapie, ed 2, rev, ext. Heidelberg, Springer, 2011.
11.
Angermann CE, Gelbrich G, Störk S, Schowalter M, Deckert J, Ertl G, Faller H: Somatic correlates of comorbid major depression in patients with systolic heart failure. Int J Cardiol 2011;147:66-73.
12.
Riedel O, Klotsche J, Spottke A, Deutschl G, Förstl H, Henn F: Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease. J Neurol 2010;257:1073-1082.
13.
Spangenberg L, Forkmann T, Brähler E, Glaesmer H: The association of depression and multimorbidity in the elderly: implications for the assessment of depression. Psychogeriatrics 2011;11:227-234.
14.
Thiem U, Hinrichs T, Müller CA, Holt-Noreiks S, Nagl A, Bucchi C, Trampisch U, Moschny A, Platen P, Penner E, Junius-Walker U, Hummers-Pradier E, Theile G, Schmiedl S, Thürmann PA, Scholz S, Greiner W, Klaassen-Mielke R, Pientka L, Trampisch HJ: Voraussetzungen für ein neues Versorgungsmodell für ältere Menschen mit Multimorbidität. Ergebnisse und Schlussfolgerungen aus 3-jähriger Forschung im PRISCUS-Verbund. Z Gerontol Geriatr 2011;44:101-112.
15.
Gunn JM, Ayton DR, Densley K, Pallant JF, Chondros P, Herrman HE, Dowrick CF: The association between chronic illness, multimorbidity and depressive symptoms in an Australian primary care cohort. Soc Psychiatry Psychiatr Epidemiol 2012;47:175-184.
16.
Spangenberg L, Forkmann T, Brähler E, Glaesmer H: The association of depression and multimorbidity in the elderly: implications for the assessment of depression. Psychogeriatrics 2011;11:227-234.
17.
Raison CL, Capuron L, Miller AH: Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006;27:24-31.
18.
Maercker A, Brewin CR, Bryant RA, Cloitre M, Ommeren M, Jones LM, Humayan A, Kagee A, Llosa AE, Rousseau C, Somasundaram DJ, Souza R, Suzuki Y, Weissbecker I, Wessely SC, First MB, Reed GM: Diagnosis and classification of disorders specifically associated with stress: proposals for ICD-11. World Psychiatry 2013;12:198-206.
19.
Wegner DM, Zanakos S: Chronic thought suppression. J Pers 1994;62:615-640.
20.
Petrie KJ, Weinman J: Why illness perceptions matter. Clin Med 2006;6:536-539.
21.
Juergens MC, Seekatz B, Moosdorf RG, Petrie KJ, Rief W: Illness beliefs before cardiac surgery predict disability, quality of life, and depression 3 months later. J Psychosom Res 2010;68:553-560.
22.
Schüz B, Wurm S, Warner LM, Ziegelmann JP: Self-efficacy and multiple illness representations in older adults: a multilevel approach. Psychol Health 2012;27:13-29.
23.
Horn AB, Maercker A: A socio-interpersonal perspective on PTSD: the case for environments and interpersonal processes. Clin Psychol Psychother 2013;20:465-481.
24.
Lyons RF, Mickelson KD, Sullivan MJL, Coyne JC: Coping as a communal process. J Soc Pers Relat 1998;15:579-605.
25.
Debrot A, Schoebi D, Perrez M, Horn AB: Touch as an interpersonal emotion regulation process in couples' daily lives: the mediating role of psychological intimacy. Pers Soc Psychol Bull 2013;39:1373-1385.
26.
Rime B: Interpersonal emotion regulation; in Gross JJ (ed): Handbook of Emotion Regulation. New York, Guilford Press, 2007, pp 466-485.
27.
Manne S, Ostroff J, Rini C, Fox K, Goldstein L, Grana G: The interpersonal process model of intimacy: the role of self-disclosure, partner disclosure, and partner responsiveness in interactions between breast cancer patients and their partners. J Fam Psychol 2004;18:589.
28.
Stadler G, Snyder KA, Horn AB, Shrout PE, Bolger NP: Close relationships and health in daily life: a review and empirical data on intimacy and somatic symptoms. Psychosom Med 2012;74:398-409.
29.
Holt-Lunstad J, Smith TB, Layton JB: Social relationships and mortality risk: a meta-analytic review. PLoS Med 2010;7:1-20.
30.
Horn AB, Pössel P, Hautzinger M: Promoting adaptive emotion regulation and coping in adolescence: a school-based programme. J Health Psychol 2011;16:258-273.
31.
Pennebaker JW, Chung CK: Expressive Writing, Emotional Upheavals, and Health. New York, Oxford University Press, 2006, pp 263-284.
32.
Smith JM: Written emotional expression: effect sizes, outcome types, and moderating variables. J Consult Clin Psychol 1998;66:174-184.
33.
Frattaroli J: Experimental disclosure and its moderators: a meta-analysis. Psychol Bull 2006;132:823-865.
34.
Bonanno GA, Westphal M, Mancini AD: Resilience to loss and potential trauma. Annu Rev Clin Psychol 2011;7:511-535.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.